Raymond L Stallings
Overview
Explore the profile of Raymond L Stallings including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
2867
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lynch J, Meehan M, Crean J, Copeland J, Stallings R, Bray I
PLoS One
. 2023 Dec;
18(12):e0295370.
PMID: 38096183
[This corrects the article DOI: 10.1371/journal.pone.0078428.].
2.
Gamble L, Purgato S, Henderson M, Di Giacomo S, Russell A, Pigini P, et al.
Cancers (Basel)
. 2021 Apr;
13(8).
PMID: 33918978
Ornithine decarboxylase (ODC1), a critical regulatory enzyme in polyamine biosynthesis, is a direct transcriptional target of MYCN, amplification of which is a powerful marker of aggressive neuroblastoma. A single nucleotide...
3.
Nolan J, Salvucci M, Carberry S, Barat A, Segura M, Fenn J, et al.
Front Cell Dev Biol
. 2020 Dec;
8:559553.
PMID: 33330445
Neuroblastoma (NB) is a neural crest-derived tumor, which develops before birth or in early childhood, with metastatic dissemination typically preceding diagnosis. Tumors are characterized by a highly heterogeneous combination of...
4.
Soriano A, Masanas M, Boloix A, Masia N, Paris-Coderch L, Piskareva O, et al.
Cell Mol Life Sci
. 2019 Feb;
76(11):2231-2243.
PMID: 30770954
Current therapies for most non-infectious diseases are directed at or affect functionality of the human translated genome, barely 2% of all genetic information. By contrast, the therapeutic potential of targeting...
5.
Smith S, Fernando T, Wu P, Seo J, Gabhann J, Piskareva O, et al.
J Autoimmun
. 2017 Mar;
79:105-111.
PMID: 28318807
Systemic lupus erythematosus (SLE) is a complex disease targeting multiple organs as a result of overactivation of the type I interferon (IFN) system, a feature currently being targeted by multiple...
6.
Spain E, Adamson K, Elshahawy M, Bray I, Keyes T, Stallings R, et al.
Analyst
. 2017 Jan;
142(5):752-762.
PMID: 28091676
Defects within a self-assembled monolayer (SAM) of dodecanethiol on gold have been used as nucleation sites for the electrodeposition of mushroom shaped platinum nanoparticles (PtNPs). The top surfaces of these...
7.
Nolan J, Stallings R, Piskareva O
Methods Mol Biol
. 2016 Nov;
1509:11-16.
PMID: 27826913
Assessment of cell viability and proliferation under different miRNA expression levels is an important step in the evaluation of basic miRNA functional effects within the cell. Here, we describe the...
8.
Soriano A, Paris-Coderch L, Jubierre L, Martinez A, Zhou X, Piskareva O, et al.
Oncotarget
. 2016 Jan;
7(8):9271-87.
PMID: 26824183
Despite multimodal therapies, a high percentage of high-risk neuroblastoma (NB) become refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or function, activating the DNA...
9.
Nolan K, Walter F, Tuffy L, Poeschel S, Gallagher R, Haunsberger S, et al.
Eur J Neurosci
. 2016 Jan;
43(5):640-52.
PMID: 26750440
Disturbance of homeostasis within the endoplasmic reticulum (ER) lumen leads to the accumulation of unfolded and misfolded proteins. This results in the activation of an evolutionary conserved stress response termed...
10.
Piskareva O, Harvey H, Nolan J, Conlon R, Alcock L, Buckley P, et al.
Cancer Lett
. 2015 May;
364(2):142-55.
PMID: 25960282
Neuroblastoma is a challenging childhood malignancy, with a very high percentage of patients relapsing following acquisition of drug resistance, thereby necessitating the identification of mechanisms of drug resistance as well...